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CONCLUSION: As a reminder, the demand for out-
patient services is deﬁned as current visits to physicians
currently, whereas in the previous OECD studies, it was
deﬁned by the number of visit to physicians (general prac-
titioner) in a certain time period (typically, one year).
Since there is no closer data to the other OECD countries
than CSLSJ in Japan, we have to survey as originally so
as to obtain the completely comparable data even though
it is expensive to do so.
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Obesity has reached epidemic proportions in the U.S. and
studies have shown that counseling obese patients can
have a signiﬁcant impact on the Nation’s health.
OBJECTIVES: The present study aims to assess pharma-
cists’ perceptions about counseling and barriers related to
counseling obese patients.
METHODS: A mail survey was sent to a random sample
of 400 Texas community pharmacists. The questionnaire
was developed using obesity literature and was pretested
among ten community pharmacists. The questionnaire
collected background information of pharmacists and
their perceptions about counseling and barriers to 
counseling. A follow up survey was sent to the 
nonrespondents.
RESULTS: Of the 400 surveys mailed, 139 were returned
completed, six were not usable and ﬁve were undeliver-
able, yielding an overall response rate of 36.7% and a
usable response rate of 35.2%. The pharmacists’ average
age was 49.5 years (SD 13). Most of the pharmacists 
were male (62.6%) and had a bachelor’s degree (94.9%)
as their highest degree. Although pharmacists counseled
obese patients rarely to sometimes, they most often 
counseled about prescribed antiobesity medications and
weight loss through diet and exercise. Pharmacists were
most comfortable counseling patients about self-help
groups and were least comfortable in counseling about
over-the-counter herbal products; however, pharmacists
perceived that the most effective weight loss treatment
was diet and exercise. The two most commonly reported
barriers to counseling obese patients were lack of time
(76.8%) and lack of patient demand (55.8%). Pharma-
cists’ counseling and barriers to counseling differed based
on various background characteristics.
CONCLUSION: Although pharmacists do not counsel
obese patients on a regular basis, they tend to counsel on
issues they are most comfortable with, namely prescribed
antiobesity medications and diet and exercise. Pharma-
cists report lack of time and patient demand as key bar-
riers they face in the community setting.
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Drug-related morbidity (DRM) results in signiﬁcant cost
and consequence. Fifty percent or more of DRM may be
preventable (PDRM). Strategies to reduce the problem of
PDRM need to be identiﬁed in order to improve the
quality of medication use.
OBJECTIVES: (1) To determine the perceived efﬁcacy of
each of eight strategies for reducing PDRM, as expressed
by physicians, and (2) whether this ranking varied
depending upon physician group.
METHODS: Three panels of physicians (twelve general
practitioners [GPs], six geriatricians and six clinical phar-
macologists) who developed and validated quality indi-
cators of PDRM in older adults, received a follow-up mail
survey to identify strategies to reduce PDRM. Each physi-
cian was asked to decide how best to reduce PDRM by
choosing from eight intervention strategies for each
quality indicator their group had developed. For each
indicator, the physician could choose from zero, to all
eight, intervention strategies.
RESULTS: The most commonly chosen strategy per
PDRM indicator was monitoring (72.5%) with health
system management (54.6%) and patient/caregiver coop-
eration (52.1%) second and third, respectively. Monitor-
ing was the most commonly chosen strategy per indicator
by the GPs (81.4%) and the clinical pharmacologists
(64.5%). The geriatricians chose health system manage-
ment most commonly as a strategy per indicator (72.5%).
Overall, an average of 3.95 intervention strategies was
chosen per clinical indicator of PDRM.
CONCLUSIONS: A survey of a group of clinicians
revealed that monitoring is perceived to be the most
important strategy to reduce PDRM among eight inter-
ventions considered. Still, it appears a combination of
intervention strategies is needed to optimally reduce
PDRM. These ﬁndings should serve to guide future
research efforts and health policy aimed at improving the
quality of medication use by minimizing PDRM in older
adults.
PHP10
USE OF HEALTH OUTCOMES DATA IN
PROMOTIONAL MATERIALS
Harris SD1, Bryant-Comstock L2
1GlaxoSmithKline, Global Health Outcomes Dept, RTP, NC &
University of North Carolina at Chapel Hill, Chapel Hill, NC,
USA; 2GlaxoSmithKline, Global Health Outcomes Dept,
Research Triangle Park, NC, USA
OBJECTIVES: Health outcomes information is being
used more frequently by the pharmaceutical industry to
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demonstrate product value beyond traditional safety and
efﬁcacy parameters. We researched country-speciﬁc regu-
lations on the use of health outcomes data for product
promotion and compared requirements/guidelines across
countries.
METHODS: We reviewed regulatory documents govern-
ing the promotion of medicines and code of practice 
documents on the enforcement of promotion guidelines.
Country-speciﬁc examples of promotional material were
collected via journal publications, electronic search and
through contact with the pharmaceutical manufacturer.
RESULTS: Regulations from 15 countries and ﬁve
regions (North America, Europe, Eastern Europe, Asia
and Latin America) were collected. The major distinc-
tions between countries are speciﬁc guidelines on the use
of health outcomes data, the ability to use qualiﬁed data
without prior approval, the level of substantiation
required for promotional use and direct-to-consumer
advertising.
CONCLUSIONS: Regulations regarding the use of health
outcomes data for product promotion are often combined
with safety and efﬁcacy guidelines. There is, however,
movement within regulatory bodies to speciﬁcally address
the use of health outcomes data. Understanding the reg-
ulation and use of health outcomes data for promotional
purposes is useful for global pharmaceutical companies
in developing a comprehensive campaign to demonstrate
product value.
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Health care costs continue to escalate. Prescription 
medications are a large contributor to both the cost and
waste of resources.
OBJECTIVES: This study investigated the number and
type of prescription drugs discarded by a nursing home.
METHODS: Nursing records of prescription drugs dis-
carded throughout ﬁscal year 2001 were analyzed. This
pilot study of one long-term, 143 bed nursing home in a
Southeastern state gives a descriptive baseline and esti-
mate of destroyed prescriptions. The number of drugs 
and associated patients, prescription names, and reasons
for destruction were categorized and analyzed. To 
enable analysis, a systematic categorization of drugs was
created.
RESULTS: Over an eleven-month period, there were
2220 prescribed drugs discarded on 227 patients. Most
of the patients (74%) in this study had between one and
eight of their prescribed drugs destroyed during this time
period. However, 27 patients (14%) had between 20 and
48 prescribed drugs discarded during this same time
period. Discarded drugs were most often for medical con-
dition categories of acute illness (17%), cardio-vascular
(17%), daily needs such as nutritional support (16%),
chronic illness (13%), and mental health (11%). The
most common reasons for destruction were medication
discontinued (51%) and patient expired (20%). This
study substantiates that many prescribed drugs are dis-
carded each month, and it is not uncommon for multiple
discards per patient.
CONCLUSIONS: Nearly half (46%) of the prescribed
drugs to nursing home residents are for long-term medical
care and maintenance, such as cardio-vascular and other
chronic illnesses and nutritional support and other per-
sonal hygiene. This study suggests that prescriptions
should be initially ﬁlled for shorter periods of time to
ensure patient compatibility and effectiveness. Also, it
appears that it would be cost effective to have pharma-
cists dispense drugs from larger vials and to repackage
already prescribed drugs.
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OBJECTIVES: Lack of knowledge is often attributed to
problematic practice by non-professional drug sellers.
Most community pharmacies in Thailand are staffed 
by non-professionals who play dual roles of prescribing
and dispensing. Training courses have been offered by
government agencies attempting to improve quality of
care by providing knowledge to drug sellers. This paper
is part of a study to evaluate effects of multiple inter-
ventions on drug seller behavior. It aims to assess effects
of training on knowledge and practice, and examine
whether practice follows knowledge, using watery diar-
rhea in children under ﬁve as tracer condition.
METHODS: A control-intervention and pre-post design
was used. Eight districts in Bangkok were selected and
matched into four pairs. Districts in each pair were ran-
domly assigned as control and intervention districts.
Seventy-eight community pharmacies were selected ran-
domly from the districts. A training program, emphasiz-
ing case management for diarrhea in children, was offered
to pharmacy staffers in the intervention group. Knowl-
edge was evaluated using open-ended questionnaire 
interviews. Dispensing practices were assessed by two
simulated client surveys. The interviews and surveys were
conducted twice—before and after training.
RESULTS: Pharmacies in both groups responded to the
case with few questions and little advice. Dispensing of
ORS only was found in 6.9 and 4.7% of the encounters
before training for the control and intervention groups
respectively. After the training, it was dispensed in 2.3%
of the encounters in the control and 3.5% in the inter-
